Protective immunity of E. coli-synthesized NS1 protein of Japanese encephalitis virus
- 18 September 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Biotechnology Letters
- Vol. 30 (2), 205-214
- https://doi.org/10.1007/s10529-007-9529-9
Abstract
Immunogenicity and protective efficacy of recombinant Japanese encephalitis virus (JEV) NS1 proteins generated using DNA vaccines and recombinant viruses have been demonstrated to induce protection in mice against a challenge of JEV at a lethal dose. The West Nile virus NS1 region expressed in E. coli is recognized by these protective monoclonal antibodies and, in this study, we compare immunogenicity and protective immunity of the E. coli-synthesized NS1 protein with another protective immunogen, the envelope domain III (ED3). Pre-challenge, detectable titers of JEV-specific neutralizing antibody were detected in the immunized mice with E. coli-synthesized ED3 protein (PRNT50 = 1:28) and the attenuated JEV strain T1P1 (PRNT50 = 1:53), but neutralizing antibodies were undetectable in the immunized mice with E. coli-synthesized NS1 protein (PRNT50 < 1:10). However, the survival rate of the NS1-immunized mice against the JEV challenge was 87.5% (7/8), showing significantly higher levels of protection than the ED3-immunized mice, 62.5% (5/8) (P = 0.041). In addition, E. coli-synthesized NS1 protein induced a significant increase of anti-NS1 IgG1 antibodies, resulting in an ELISA titer of 100,1000 in the immunized sera before lethal JEV challenge. Surviving mice challenged with the virulent JEV strain Beijing-1 showed a ten-fold or greater rise in IgG1 and IgG2b titers of anti-NS1 antibodies, implying that the Th2 cell activation might be predominantly responsible for antibody responses and mice protection.Keywords
This publication has 26 references indexed in Scilit:
- Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc γ Receptor-Dependent and -Independent MechanismsJournal of Virology, 2006
- Mutations in the NS3 Gene and 3′-NCR of Japanese Encephalitis Virus Isolated from an Unconventional Ecosystem and Implications for Natural Attenuation of the VirusVirology, 2001
- Fragment of Japanese encephalitis virus envelope protein produced in Escherichia coli protects mice from virus challengeMicrobial Pathogenesis, 2001
- The molecular basis of virulence of the encephalitogenic flaviviruses.Journal of General Virology, 1997
- Poxvirus-Based Japanese Encephalitis Vaccine Candidates Induce JE Virus-Specific CD8+Cytotoxic T Lymphocytes in MiceVirology, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Purification and Renaturation of Japanese Encephalitis Virus Nonstructural Glycoprotein NS1 Overproduced by Insect CellsProtein Expression and Purification, 1995
- A vipox virus-vectored Japanese encephalitis virus vaccines: use as vaccine candidates in combination with purified subunit immunogensVaccine, 1994
- Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNAVirology, 1990
- Evaluation of the Potency and Safety of Inactivated Japanese Encephalitis Vaccine in US InhabitantsThe Journal of Infectious Diseases, 1990